Electrocardiographic and Electrophysiologic Changes After Percutaneous Closure of Atrial Septal Defect

Launched by ASSIUT UNIVERSITY · Jan 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a procedure called percutaneous closure for a specific type of heart defect known as atrial septal defect (ASD). The researchers want to understand how this procedure affects the heart's electrical system, particularly focusing on two important areas: the sinoatrial node (SAN) and the atrioventricular node (AVN), which help control the heart's rhythm. They will look at how often these areas have problems both before and after the procedure, and will also examine factors that might influence these outcomes.

To participate in this study, individuals aged 65 to 74 who have been diagnosed with secundum ASD and are eligible for the closure procedure at Assiut University Heart Hospital may be considered. There are no specific exclusions for this trial, meaning anyone fitting the age and diagnosis criteria can potentially join. Those who take part will undergo tests to monitor their heart's electrical activity before and after the procedure, helping the researchers gather important information on how the treatment impacts heart function.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients presented with secundum ASD eligible for percutaneous transcatheter ASD closure at Assiut university heart hospital
• Exclusion Criteria:
• • No exclusion